Ubiquitin And Proteasome Pathways
16 researchers across 4 institutions
Research in ubiquitin and proteasome pathways investigates the fundamental cellular processes governing protein degradation and regulation. This field examines how the ubiquitin-proteasome system tags proteins for destruction, influences cellular signaling, and responds to various cellular stresses. Investigations employ biochemical, genetic, and structural biology approaches to understand the molecular mechanisms of ubiquitination and deubiquitination enzymes, the structure and function of the proteasome, and the roles these pathways play in maintaining cellular homeostasis. Specific areas of focus include the involvement of these pathways in DNA repair, cell cycle control, immune responses, and the pathogenesis of diseases such as cancer and neurodegenerative disorders.
This research holds significant relevance for Arkansas by contributing to advancements in public health and biotechnology. Understanding protein degradation mechanisms is crucial for developing novel therapeutic strategies for diseases prevalent in the state, including various cancers and age-related conditions. Furthermore, insights gained from this field can inform the development of new biotechnological tools and platforms, potentially supporting the growth of the state's bioscience and pharmaceutical sectors. The fundamental nature of this research also underpins broader efforts to understand genetic disorders and metabolic dysregulation, areas of public health concern.
This area of study is inherently interdisciplinary, drawing connections to receptor mechanisms, signaling pathways, protein structure, and metabolism. Engagement across multiple Arkansas institutions fosters a collaborative environment, bringing together diverse expertise to address complex biological questions and their implications for human health and biotechnological innovation.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| Cam Patterson | UAMS | 94 | 42,822 | High Impact | |
| Robert J. Shmookler Reis | UAMS | 45 | 5,965 | Faculty | Grant PI High Impact |
| Bin Dong | University of Arkansas | 35 | 4,312 | Faculty | Grant PI High Impact |
| Amy Baldwin | University of Central Arkansas | 26 | 3,046 | High Impact | |
| Pamela Pennington Lockyer | UAMS | 20 | 1,468 | Grants | |
| Nirmala Parajuli | UAMS | 16 | 6,895 | Faculty | Grant PI |
| Graham M. Strub | UAMS | 11 | 3,364 | Faculty | |
| Subramaniam Ponnappan | UAMS | 11 | 584 | ||
| Sadia Hamera | UA Little Rock | 10 | 766 | ||
| Crystal R. Archer | University of Arkansas | 9 | 503 | Faculty | Grant PI |
| Jingwei Shao | UAMS | 8 | 386 | ||
| Sorena Lo | UAMS | 6 | 77 | ||
| Val H. Irion | UAMS | 5 | 94 | ||
| Srihari Shankar | UAMS | 4 | 47 | ||
| Nicole M. Poquette | University of Arkansas | 2 | 86 | ||
| Matthew Deneke | UAMS | 0 | 0 | Faculty |
Related Research Areas
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 Harvard University 4,016
- 2 Howard Hughes Medical Institute 2,406
- 3 National Institutes of Health 2,021
- 4 The University of Texas MD Anderson Cancer Center 2,019
- 5 Dana-Farber Cancer Institute 1,921
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Ubiquitin And Proteasome Pathways.